Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Triptans versus analgesics.

Lawrence Robbins1

  • 1Department of Neurology, Rush Medical College, Chicago, IL 60062, USA.

Headache
|October 23, 2002
PubMed
Summary
This summary is machine-generated.

Most migraine patients prefer triptans over analgesics due to enhanced efficacy. Even with limitations, 70% of past triptan users continued their preference for these migraine treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution and Migraine.

Headache·2020
Same author

Erenumab Side Effects.

Headache·2019
Same author

CGRP Antagonists: Physiologic Effects and Serious Side Effects.

Headache·2018
Same author

Refractory migraine.

Headache·2015
Same author

Cranial neuralgia vs entrapment neuropathy decompression … better names than migraine trigger site deactivation surgery.

Headache·2015
Same author

Medication overuse headache: inaccurate and overdiagnosed.

Headache·2014
Same journal

Essential readings in headache medicine: Top 10 educational articles from 2025.

Headache·2026
Same journal

Pain reduction and tolerability of mirogabalin in trigeminal neuralgia: A prospective observational study.

Headache·2026
Same journal

Risk of hypertension after CGRP antagonist treatment in migraine: A systematic review and meta-analysis.

Headache·2026
Same journal

Nummular headache responsive to suzetrigine, a novel, selective sodium channel antagonist.

Headache·2026
Same journal

Sexual dysfunction is underrecognized in patients with migraine: A systematic review and meta-analysis.

Headache·2026
Same journal

College students' migraine perceptions and lived experiences: A qualitative study.

Headache·2026
See all related articles

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Medicine

Background:

  • Migraine headaches are a common neurological condition.
  • Treatment options include triptans and analgesics.
  • Patient preference is a key factor in treatment adherence.

Purpose of the Study:

  • To evaluate patient preferences for triptans versus analgesics in migraine management.
  • To identify reasons behind patient choices between triptans and analgesics.

Main Methods:

  • Retrospective survey of 663 migraine patients (ages 17-62).
  • Data collected over a 3-month period in an office-based setting.
  • Assessed preferences for triptans alone, triptans with analgesics, or analgesics alone.

Related Experiment Videos

Main Results:

  • 70% of patients preferred triptans (alone or with analgesics).
  • Increased efficacy was the primary reason for triptan preference (62%).
  • 21% preferred analgesics alone, and 9% preferred neither.

Conclusions:

  • Most migraine patients prefer triptans despite potential cost and limitations.
  • Enhanced efficacy is the main driver for choosing triptans over analgesics.
  • Patient-centered treatment decisions are crucial for effective migraine management.